Menu
Peptide Database
Results
No peptides found
Featured

Use search to browse all 100+ peptides

Kisspeptin-10

KP-10, Metastin (45-54), Kisspeptin-10 (human), KiSS-1

Quick Stats
Studies 877
Trials 47
Score 2
2015 pubmed 34 citations

RF9 Acts as a KISS1R Agonist In Vivo and In Vitro.

Min. Le L; Leon. Silvia S; Li. Huan H; Pinilla. Leonor L; Carroll. Rona S RS; Tena-Sempere. Manuel M; Kaiser. Ursula B UB

Key Findings

  • RF9 binds specifically to KISS1R with a Kd of 1.6 × 10⁻⁵ M
  • RF9 triggers calcium rise, inositol phosphate production, and ERK activation similar to kisspeptin‑10
  • RF9 raises LH levels in normal mice but not in Kiss1r‑knockout mice, confirming KISS1R dependence

Practical Outcomes

  • RF9 could be used as a research tool to mimic kisspeptin‑10 effects, but it isn’t a ready‑to‑use supplement for humans. For biohackers, the finding mainly cautions against assuming RF9 works via other pathways and highlights kisspeptin‑based strategies as the relevant route for influencing LH and related functions.

Summary

The study shows that the compound RF9, previously thought to block a different hormone receptor, actually works like kisspeptin-10 by activating the kisspeptin receptor (KISS1R) and boosting luteinizing hormone (LH) in mice. This means RF9 isn’t useful for studying the other receptor and its main effect is through the kisspeptin pathway.

Abstract

RF9, a reported antagonist of the mammalian gonadotropin-inhibitory hormone receptor, stimulates gonadotropin secretion in mammals. Recent studies have suggested that the stimulatory effect of RF9 on gonadotropin secretion relies on intact kisspeptin receptor (KISS1R) signaling, but the underlying mechanisms remain to be elucidated. Using Chinese Hamster Ovary cells stably transfected with KISS1R, we show that RF9 binds specifically to KISS1R, with a Kd of 1.6 × 10(-5)M, and stimulates an increase in intracellular calcium and inositol phosphate accumulation in a KISS1R-dependent manner, with EC50 values of 3.0 × 10(-6)M and 1.6 × 10(-7)M, respectively. RF9 also stimulated ERK phosphorylation, with a time course similar to that of kisspeptin-10. RFRP-3, the putative endogenous ligand for NPFFR1, did not stimulate inositol phosphate accumulation or pERK, nor did it alter responses to of kisspeptin-10 or RF9. In agreement with these in vitro data, we found that RF9 stimulated a robust LH increase in Npffr1(-/-) mice, similar to that in wild-type littermates, whereas the stimulatory effect of RF9 was markedly reduced in Kiss1r(-/-) and double Kiss1r(-/-)/Npfrr1(-/-) mice. The stimulatory effect of RF9 on LH secretion was restored by the selective rescue of Kiss1r expression in GnRH neurons, in Kiss1r(-/-T) mice. Taken together, our study demonstrates that RF9 acts primarily as a KISS1R agonist, but not as an allosteric modulator, to stimulate LH secretion. Our findings raise questions regarding the utility of RF9 for assessing NPFF1R function and de-emphasize a predominant role of this signaling system in central regulation of reproduction.

Study Information

Provider

pubmed

Year

2015

Date

2015-09-29T00:00:00.000Z

DOI

10.1210/en.2015-1635

Citations

34

References

45